Literature DB >> 10486397

Range of neuropsychiatric disturbances in patients with Parkinson's disease.

D Aarsland1, J P Larsen, N G Lim, C Janvin, K Karlsen, E Tandberg, J L Cummings.   

Abstract

OBJECTIVES: Disturbances of cognition and emotion are common in patients with Parkinson's disease. Most previous studies of psychopathology in Parkinson's disease have focused on a single psychiatric diagnosis or condition. The objective of this study was to describe the range of neuropsychiatric symptoms in a representative sample of patients with Parkinson's disease.
METHODS: The sample of 139 patients was drawn from an epidemiological study of Parkinson's disease in Rogaland county, Norway, and represented 93% of those who had survived during the 4 years since the initial assessment. The diagnosis of Parkinson's disease was based on published criteria. Neuropsychiatric symptoms were assessed using the neuropsychiatric inventory, a caregiver based structured interview, which assesses severity and frequency of 10 psychiatric symptoms present during the past month.
RESULTS: At least one psychiatric symptom was reported in 61% of the sample. The most common behaviours were depression (38%) and hallucinations (27%), and the least common symptoms were euphoria and disinhibition. The highest mean scores were found for depression, apathy, and hallucinations. Factor analysis showed that hallucinations, delusions, and irritability clustered into one factor, and apathy and anxiety constituted another factor. Psychiatric symptoms were more common among patients living in nursing homes compared with home dwelling patients, and correlated with stage of disease and cognitive impairment, but not with age or duration of disease. No relation to left or right sided parkinsonism was found.
CONCLUSION: This study emphasises the importance of psychiatric symptoms in Parkinson's disease, which were present in most patients. Clinicians should focus on the emotional and cognitive disturbances in addition to the motor manifestations of the disease.

Entities:  

Mesh:

Year:  1999        PMID: 10486397      PMCID: PMC1736593          DOI: 10.1136/jnnp.67.4.492

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  22 in total

1.  Neuropsychiatric aspects of progressive supranuclear palsy.

Authors:  I Litvan; M S Mega; J L Cummings; L Fairbanks
Journal:  Neurology       Date:  1996-11       Impact factor: 9.910

Review 2.  Cognitive deficits in Parkinson's disease.

Authors:  B Dubois; B Pillon
Journal:  J Neurol       Date:  1997-01       Impact factor: 4.849

3.  Alzheimer disease and frontotemporal dementias. Behavioral distinctions.

Authors:  M L Levy; B L Miller; J L Cummings; L A Fairbanks; A Craig
Journal:  Arch Neurol       Date:  1996-07

Review 4.  Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence.

Authors:  J P Larsen; E Dupont; E Tandberg
Journal:  Acta Neurol Scand       Date:  1994-04       Impact factor: 3.209

5.  Risk factors for depression in Parkinson disease.

Authors:  E Tandberg; J P Larsen; D Aarsland; K Laake; J L Cummings
Journal:  Arch Neurol       Date:  1997-05

6.  Depression in classic versus akinetic-rigid Parkinson's disease.

Authors:  S E Starkstein; G Petracca; E Chemerinski; A Tesón; L Sabe; M Merello; R Leiguarda
Journal:  Mov Disord       Date:  1998-01       Impact factor: 10.338

Review 7.  Anxiety and Parkinson's disease.

Authors:  I H Richard; R B Schiffer; R Kurlan
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1996       Impact factor: 2.198

8.  Depression and disability in Parkinson's disease.

Authors:  S A Cole; J L Woodard; J L Juncos; J L Kogos; E A Youngstrom; R L Watts
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1996       Impact factor: 2.198

9.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

10.  The spectrum of behavioral changes in Alzheimer's disease.

Authors:  M S Mega; J L Cummings; T Fiorello; J Gornbein
Journal:  Neurology       Date:  1996-01       Impact factor: 9.910

View more
  129 in total

Review 1.  Apathy in neurologic disorders.

Authors:  J Duffy
Journal:  Curr Psychiatry Rep       Date:  2000-10       Impact factor: 5.285

Review 2.  Neuropsychiatry of the basal ganglia.

Authors:  H A Ring; J Serra-Mestres
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

3.  Nonrecognition of depression in Parkinson's disease.

Authors:  Karen E Anderson
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

4.  Apathy in Parkinson's disease.

Authors:  G C Pluck; R G Brown
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

5.  Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa.

Authors:  D A M C van de Vijver; R A C Roos; P A F Jansen; A J Porsius; A de Boer
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

Review 6.  [Deep brain stimulation for Parkinson's disease].

Authors:  J Herzog; G Deuschl
Journal:  Nervenarzt       Date:  2010-06       Impact factor: 1.214

Review 7.  Late-stage Parkinson disease.

Authors:  Miguel Coelho; Joaquim J Ferreira
Journal:  Nat Rev Neurol       Date:  2012-07-10       Impact factor: 42.937

8.  Psychosis and concurrent impulse control disorder in Parkinson's disease: A review based on a case report.

Authors:  Bruno Fukelmann Guedes; Marcia Rubia Gonçalves; Rubens Gisbert Cury
Journal:  Dement Neuropsychol       Date:  2016 Apr-Jun

Review 9.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

10.  Neuropsychiatric symptoms and striatal monoamine availability in early Parkinson's disease without dementia.

Authors:  Yoon-Sang Oh; Jean Hee Kim; Sang-Won Yoo; Eo-Jin Hwang; Chul Hyoung Lyoo; Kwang-Soo Lee; Joong-Seok Kim
Journal:  Neurol Sci       Date:  2020-10-31       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.